| Marketing & Distribution |
|
The marketing and distribution of medical products in China such as pharmaceuticals and medical devices is particularly complex because the market is greatly influenced by the government policies such as reimbursement, regulation and pricing policies over medical products. In addition, non-efficient distribution system and the government ownership in the majority of hospitals both add additional complexities to the market place.
Over years, China Healthcare Group has dedicated significant resource in developing marketing and distribution networks in China through the strategic relationships with local medical product distributors and marketing companies. Tapping into the existing distribution network can readily help our clients reach their sales target. Today, we have represented the companies from the United States and Europe to market their leading medical products in China and Korea with great success.
The products we currently represent fall into the following niche markets:
We continue to source technologically advanced medical products that not only address unmet clinical need but also has great market potential.
Testimonial“China Healthcare Group, with their in-depth biomedical industry knowledge complimented by their professionalism and dedication, has been a very valuable addition to our efforts to expand sales in the Asian markets"Jack McMaken, CEO of AcryMed, Inc., the United States |
| < Prev | Next > |
|---|
Service Activities
Industrial News
- China Aoxing Pharmaceutical Company Receives Government Approval for Increased Ownership of its Main
- Reform to target hefty medicine costs
- China to develop traditional medicine vigorously
- Novartis to move Indian R&D operations to China: Financial Times
- India and China competing on pharma potential